Literature DB >> 22178921

Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity.

Vito de Novellis1, Livio Luongo, Francesca Guida, Luigia Cristino, Enza Palazzo, Roberto Russo, Ida Marabese, Giuseppe D'Agostino, Antonio Calignano, Francesca Rossi, Vincenzo Di Marzo, Sabatino Maione.   

Abstract

Palmitoylethanolamide (PEA), a peroxisome proliferator-activated receptor-α (PPAR-α) ligand, exerts antinociceptive and anti-inflammatory effects. PEA (3 and 6 nmol) was microinjected in the ventrolateral periaqueductal grey (VL PAG) of male rats and effects on nociceptive responses and ongoing and tail flick-related activities of rostral ventromedial medulla (RVM) ON and OFF cells were recorded. Intra-PAG microinjection of PEA reduced the ongoing activity of ON and OFF cells and produced an increase in the latency of the nociceptive reaction. These effects were prevented by a selective PPAR-α antagonist, GW6471 and by a large-conductance Ca(2+)-activated K(+) channel inhibitor, charybdotoxin. Cannabinoid 1 (CB(1)) receptor blockade by AM251 increased the PEA-induced effect both on the ongoing activity of the ON cell and on the latency to tail flick without affecting the effect of PEA on the OFF cell. Conversely, a transient receptor potential vanilloid type 1 (TRPV(1)) blocker, I-RTX, had no effect on the ON cell activity and tail flick latency, whereas it blocked the PEA-induced decrease in ongoing activity of the OFF cell. PEA decreased the burst and increased the latency of tail flick-evoked onset of ON cell activity in a manner antagonised by GW6471 and charybdotoxin. AM251 and I-RTX, instead, enhanced these latter effects. In conclusion, intra-VL PAG PEA induces antinociceptive effects associated with a decrease in RVM ON and OFF cell activities. PPAR-α receptors mediate, and CB(1) and TRPV(1) receptors antagonise, PEA-induced effects within the PAG-RVM circuitry.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178921     DOI: 10.1016/j.ejphar.2011.11.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

Review 1.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

2.  Opioids disrupt pro-nociceptive modulation mediated by raphe magnus.

Authors:  Kevin M Hellman; Peggy Mason
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

Review 3.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

Review 4.  PPARs and pain.

Authors:  Bright N Okine; Jessica C Gaspar; David P Finn
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

Review 5.  Medullary circuits for nociceptive modulation.

Authors:  Peggy Mason
Journal:  Curr Opin Neurobiol       Date:  2012-04-06       Impact factor: 6.627

6.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 7.  Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.

Authors:  Stephen D Skaper; Laura Facci
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 8.  Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

9.  Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.

Authors:  Francesca Borrelli; Barbara Romano; Stefania Petrosino; Ester Pagano; Raffaele Capasso; Diana Coppola; Giovanni Battista; Pierangelo Orlando; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

Review 10.  Mast cells, glia and neuroinflammation: partners in crime?

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.